Start here if you're new
what it is
Great Elm Group is a small holding company that sells medical equipment and manages investments.
how it gets paid
Last year Great Elm made $16M in revenue. investment management was the main engine at $9M, or 56% of sales.
growth snapshot
Revenue was roughly flat last year at $16M. Revenue was up 358% vs. prior year, helped by MCS acquired in February 2025.
what just happened
Revenue reached $14M, but EPS still came in at -$0.75.
At a glance
C+ balance sheet — struggling to keep the lights on
25/100 earnings predictability — expect surprises
7.7x trailing p/e — the market's not buying it — or you found a deal
11.4% return on capital — nothing to write home about
$0.38 fy2025 eps est
xvary composite: 38/100 — weak
What they do
Great Elm Group is a small holding company that sells medical equipment and manages investments.
You are buying a two-line business, not a brand empire. Durable medical equipment gives repeat demand, and investment management adds fee income. The punchline is the scale: $16M in annual revenue and 50 employees mean every dollar matters.
How they make money
$16M
annual revenue · their business grew +0.0% last year
investment management
$9M
respiratory care equipment
$4M
sleep study services
$2M
medical equipment rental
$1M
The products that matter
manages third-party capital
Asset Management
$10.8M · 67.5% of revenue
This is the core fee business, and it still brought in $10.8M of the company's $16M annual revenue. The problem is the 72% decline. When your main segment shrinks that fast, every other number gets less forgiving.
largest segment
owns operating stakes
Corporate Investments
$5.2M · 32.5% of revenue
This bucket contributed $5.2M of annual revenue, but the latest quarter also included a $14.4M unrealized investment loss. That's the trade-off. These holdings can add upside, but they can also swamp the income statement.
mark-to-market risk
Key numbers
$16M
annual revenue
This is the whole top line. A company this small does not get the luxury of sloppy execution.
7.7x
trailing p/e
You are paying 7.7 times trailing earnings, which is cheap until the earnings disappear.
49.1%
operating margin
The business loses about half of each sales dollar before the bottom line shows up.
$62M
long-term debt
Debt is almost four times annual revenue. That is a loud number for a $67M company.
Financial health
C+
strength
- balance sheet grade C+ — weak — may struggle to fund operations
- risk rank 3 — safer than 50% of stocks
- price stability 35 / 100
- long-term debt $62M (48% of capital)
C+ — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for GEG right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue reached $14M, but EPS still came in at -$0.75.
Revenue was up 358% vs. prior year, helped by MCS acquired in February 2025. The profit line did not keep up.
$14M
revenue
-$0.75
eps
n/a
n/a
the number that mattered
Revenue was $14M. That is the part that got bigger. EPS was still negative, which is the part that still hurts.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is investment markdowns overwhelming a tiny revenue base. Great Elm generated $3M of quarterly revenue and still reported a $(16.5)M net loss because a $(14.4)M unrealized loss hit the income statement.
high
investment marks can swamp the quarter
The latest quarter included a $(14.4)M unrealized loss versus just $3M of revenue. That means portfolio valuation moves had more impact than the operating business.
If this repeats, reported earnings stay noisy and the 7.7x trailing P/E stops meaning much.
high
debt is large relative to the equity story
Long-term debt is $62M, which is 48% of capital, against a market cap of roughly $67M. That's a lot of leverage for a business with $16M of annual revenue.
A weak operating stretch leaves less room to refinance, invest, or absorb another bad quarter.
med
financial reporting control risk is already on the page
SEC filings from june 2023 and 2024 cite risk around not detecting a material misstatement in the financial statements. That is a specific credibility risk, not a generic footnote.
If controls slip, you are dealing with regulatory pressure and trust damage at the same time.
The combined picture is simple: a $(14.4)M investment loss, $62M of debt, and a n/a net margin leave very little room for another bad quarter.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
next earnings report
Estimated for may 6, 2026. You want to see whether revenue rebounds from $3M and whether another investment mark dominates the quarter.
revenue
asset management stabilization
Asset management produced $10.8M of annual revenue and fell 72%. If the core fee stream keeps shrinking, the business gets even more dependent on volatile investment results.
balance sheet
debt versus market value
Long-term debt is $62M against a market cap near $67M. That ratio is uncomfortable for a company with 35 / 100 price stability.
capital return
share buyback pace
The company repurchased 6.4M shares at an average price of $1.99 through feb 3, 2026. Buybacks can help per-share math, but only if the operating business stops bleeding.
Analyst rankings
earnings predictability
25 / 100
In human-speak, analysts do not trust the earnings stream to show up in a smooth line.
risk rank
3
This sits around the middle of the pack. It is not a meltdown score, but it is nowhere near a safety badge.
price stability
35 / 100
The stock tends to move around. With a $67M market cap, that's what thin liquidity looks like.
source: institutional data
Institutional activity
institutional ownership data for GEG is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$2
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive